Vir Biotechnology, Inc. VIR Фондовый прогноз
ИИ-прогноз цены и анализ для Vir Biotechnology, Inc. · Обновленный Мар 13, 2026
ИИ-прогноз на 90 дней
ДЕРЖАТЬ
7 дней
30 дней
90 дней
Уверенность AI: 19% Корреляция Спирмена
Март 13, 2026
Посмотреть точную целевую цену VIR
Создайте бесплатный аккаунт, чтобы разблокировать ИИ-прогнозы для более 4 000 акций
Зарегистрируйтесь бесплатно через Google✓ Бесплатный аккаунт · ✓ Пробный период 30 дней · ✓ Отмена в любое время
График цен
Загрузка графика...
Ключевые показатели
Рыночная капитализация
$1.47B
Коэффициент P/E
-2,0x
Коэффициент P/B
1,84x
EPS
$-4,01
ROE
91,7%
Чистая маржа
-678,4%
Выручка
$68M
Коэффициент текущей ликвидности
3,66x
Коэффициент D/E
0,07x
О сайте Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) работает в секторе Life Sciences, в частности в отрасли Biological Products, (No Diagnostic Substances). В компании работает около 562 сотрудников.
We do not have any company description for Vir Biotechnology, Inc. at the moment.
Biological Products, (No Diagnostic Substances) Сопоставимые компании
| Компания | Тикер | ИИ-сигнал | Рыночная капитализация | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $170M | -1,9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74,1x |
| Alpha Cognition Inc. | ACOG | ██% | $116M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.18B | 14,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $1.98B | -4,6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $114M | 995,1x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0,5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $223M | -1,2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $41M | -19,2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $509M | -1,4x |
| Alvotech | ALVO | ██% | $1.07B | -x |
| Amgen Inc | AMGN | ██% | $189.58B | 24,6x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.38B | -20,5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $41.93B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $315M | -1,0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $133M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $35M | 1,1x |
| Atyr Pharma Inc | ATYR | ██% | $76M | -3,6x |
| Aura Biosciences, Inc. | AURA | ██% | $425M | -4,9x |
| Autolus Therapeutics Plc | AUTL | ██% | $386M | -x |
| Anavex Life Sciences … | AVXL | ██% | $261M | -17,3x |
| Bioatla, Inc. | BCAB | ██% | $13M | -1,1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0,6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $8M | -4,9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.37B | 9,0x |
| Black Diamond Therapeutics, … | BDTX | ██% | $116M | 5,2x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.23B | -12,6x |
| Biogen Inc. | BIIB | ██% | $27.54B | 21,3x |
| Biontech Se | BNTX | ██% | $21.43B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $286M | -1,6x |
| Candel Therapeutics, Inc. | CADL | ██% | $328M | -4,6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $228M | -2,6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3,4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $720K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $847M | -4,1x |
| Compugen Ltd | CGEN | ██% | $188M | -x |
| Cg Oncology, Inc. | CGON | ██% | $5.16B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $68M | -0,5x |
| Coherus Oncology, Inc. | CHRS | ██% | $265M | 1,6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0,9x |
| Cellectis S.A. | CLLS | ██% | $319M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $909M | -4,8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $106M | -4,0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $136M | -x |
| Curis Inc | CRIS | ██% | $20M | -0,3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.25B | -12,1x |
| Champions Oncology, Inc. | CSBR | ██% | $80M | 32,9x |
| Cel Sci Corp | CVM | ██% | $26M | -0,9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.13B | -3,3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $319M | -13,9x |
| Denali Therapeutics Inc. | DNLI | ██% | $2.82B | -8,7x |
| Precision Biosciences Inc | DTIL | ██% | $131M | -2,2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7,3x |
| Editas Medicine, Inc. | EDIT | ██% | $218M | -0,8x |
| Elutia Inc. | ELUT | ██% | $44M | 0,8x |
| Engene Holdings Inc. | ENGN | ██% | $414M | 3,7x |
| Entera Bio Ltd. | ENTX | ██% | $51M | 8,5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $42M | -3,1x |
| Evaxion A/S | EVAX | ██% | $31M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.01B | 14,1x |
| Exozymes Inc. | EXOZ | ██% | $61M | -x |
| Fate Therapeutics Inc | FATE | ██% | $122M | -1,3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $438M | -3,0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $210M | 1758,3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | -0,1x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $169.20B | 19,9x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.32B | 59,5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.32B | 23,1x |
| Humacyte, Inc. | HUMA | ██% | $128M | -3,3x |
| Immunitybio, Inc. | IBRX | ██% | $6.74B | -3,6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $194M | -1,0x |
| Immunocore Holdings Plc | IMCR | ██% | $1.48B | -x |
| Immatics N.V. | IMTX | ██% | $1.25B | -x |
| Immunovant, Inc. | IMVT | ██% | $4.85B | -14,5x |
| In8bio, Inc. | INAB | ██% | $13M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1,5x |
| Inmune Bio, Inc. | INMB | ██% | $30M | -2,5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2,2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.45B | -4,5x |
| Century Therapeutics, Inc. | IPSC | ██% | $365M | -0,7x |
| Invivyd, Inc. | IVVD | ██% | $367M | -0,4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $25M | -3,2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $121M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.35B | -2,5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.21B | 35,2x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.46B | -17,8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $458M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $360M | -4,7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $357M | -6,7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $10M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $385M | -0,4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $1.90B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $596M | -3,4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $160M | -x |
| Moderna, Inc. | MRNA | ██% | $20.02B | -3,2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $12.80B | 26,7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $399M | -3,9x |
| Novavax Inc | NVAX | ██% | $1.51B | 3,4x |
| Ocugen, Inc. | OCGN | ██% | $547M | -4,3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0,2x |
| Palisade Bio, Inc. | PALI | ██% | $291M | -0,2x |
| Passage Bio, Inc. | PASG | ██% | $22M | -0,6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.62B | -20,4x |
| Biomx Inc. | PHGE | ██% | $8M | 1,5x |
| Pluri Inc. | PLUR | ██% | $34M | -1,4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $173M | 41,2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | 0,3x |
| Prime Medicine, Inc. | PRME | ██% | $617M | -1,5x |
| Prokidney Corp. | PROK | ██% | $526M | -x |
| Qiagen N.V. | QGEN | ██% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1,7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $602M | -3,8x |
| Repligen Corp | RGEN | ██% | $6.61B | 135,2x |
| Regenxbio Inc. | RGNX | ██% | $418M | -1,8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.84B | -2,0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.08B | -11,1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.58B | -4,7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $273M | 20,6x |
| Sana Biotechnology, Inc. | SANA | ██% | $740M | -2,1x |
| Scilex Holding Co | SCLX | ██% | $47M | -0,4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287,8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $82M | -1,6x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -0,9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $24M | -1,1x |
| Scholar Rock Holding … | SRRK | ██% | $5.22B | -18,5x |
| Surrozen, Inc./De | SRZN | ██% | $343M | -0,5x |
| Sutro Biopharma, Inc. | STRO | ██% | $356M | -1,0x |
| Protara Therapeutics, Inc. | TARA | ██% | $278M | -2,1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.87B | -12,4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4,6x |
| Bio-Techne Corp | TECH | ██% | $8.20B | 101,1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -8,9x |
| Instil Bio, Inc. | TIL | ██% | $56M | -1,1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $159M | -2,5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.26B | -3,0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $17M | -x |
| Twist Bioscience Corp | TWST | ██% | $2.85B | -12,6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $372M | 41,3x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $548M | -x |
| Vericel Corp | VCEL | ██% | $1.61B | 97,7x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2,0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $738M | -0,6x |
| Vaxart, Inc. | VXRT | ██% | $146M | 8,9x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $238M | 570,6x |
| Windtree Therapeutics Inc … | WINT | ██% | $320K | -0,4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $375M | 6,4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $26M | -31,3x |
| Zura Bio Ltd | ZURA | ██% | $565M | -x |
Частые вопросы
-
Стоит ли покупать акции Vir Biotechnology, Inc.?
Наш ИИ анализирует Vir Biotechnology, Inc. ежедневно. Проверьте сигнал выше для последней рекомендации. Всегда проводите собственное исследование перед инвестированием.
-
Насколько точны прогнозы Vir Biotechnology, Inc.?
Наш ИИ достигает корреляции Спирмена 19% для этой акции, со средней точностью выше 67% по более чем 4 000 акциям, анализируемым ежедневно.
-
Как часто обновляются прогнозы?
Прогнозы Vir Biotechnology, Inc. обновляются ежедневно с использованием последних рыночных данных и ИИ-моделей.
Готовы инвестировать умнее?
Присоединяйтесь к тысячам инвесторов, использующих ИИ-прогнозы акций
Зарегистрироваться бесплатно✓ Бесплатный аккаунт · ✓ Более 4 000 акций · ✓ Ежедневные обновления
Ищете более глубокий анализ Vir Biotechnology, Inc.?
Посмотреть полный институциональный анализ на Intratio →ИИ-прогнозы основаны на исторических закономерностях и не должны быть единственным основанием для инвестиционных решений. Прошлые результаты не гарантируют будущих доходов. Всегда проводите собственное исследование.